Cardiovascular Diseases And Psychiatric Disorders During The Diagnostic Workup Of Suspected Hematological Malignancy

References

• Yu AF, Jones LW. Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training. Future Cardio. 2015;11(4):441–452. doi:10.2217/fca.15.29
   PubMed Web of Science ®Google Scholar
• van Leeuwen FE, Ng AK. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment. Hematology Am Soc Hematol Edu Program. 2016;2016(1):323–330. doi:10.1182/asheducation-2016.1.323
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–174. doi:10.1016/S1470-2045(11)70002-X21251875
   PubMed Web of Science ®Google Scholar
• Mehnert A, Brahler E, Faller H, et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol. 2014;32(31):3540–3546. doi:10.1200/JCO.2014.56.008625287821
   PubMed Web of Science ®Google Scholar
• Loberiza FR Jr., Rizzo JD, Bredeson CN, et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002;20(8):2118–2126. doi:10.1200/JCO.2002.08.75711956273
   PubMed Web of Science ®Google Scholar
• Wasterlid T, Mohammadi M, Smedby KE, et al. Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study. J Int Med. 2019;285(4):455–468. doi:10.1111/joim.12849
   PubMed Web of Science ®Google Scholar
• Mohammadi M, Cao Y, Glimelius I, Bottai M, Eloranta S, Smedby KE. The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study. BMC Cancer. 2015;15:850. doi:10.1186/s12885-015-1857-x26537111
   PubMed Web of Science ®Google Scholar
• Lopez-Fernandez T, Martin Garcia A, Santaballa Beltran A, et al. Cardio-Onco-hematology in clinical practice. Position paper and recommendations. Rev Esp Cardiol (English ed). 2017;70(6):474–486. doi:10.1016/j.rec.2016.12.041.
   PubMed Web of Science ®Google Scholar
• Jurczak W, Szmit S, Sobocinski M, et al. Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study. Int J Cardiol. 2013;168(6):5212–5217. doi:10.1016/j.ijcard.2013.08.03323998543
   PubMed Web of Science ®Google Scholar
• Farhangi H, Badiei Z, Moharreri F. Prevalence of psychiatric symptoms in all patients during maintenance therapy. Iran J Ped Hematol Oncol. 2015;5(2):77–82.26131345
   PubMedGoogle Scholar
• Bagur J, Massoubre C, Casagranda L, Faure-Conter C, Trombert-Paviot B, Berger C. Psychiatric disorders in 130 survivors of childhood cancer: preliminary results of a semi-standardized interview. Pedia Blood Cancer. 2015;62(5):847–853. doi:10.1002/pbc.25425
   Web of Science ®Google Scholar
• van Nimwegen FA, Schaapveld M, Janus CP, et al. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. JAMA Int Med. 2015;175(6):1007–1017. doi:10.1001/jamainternmed.2015.1180
   PubMed Web of Science ®Google Scholar
• van Nimwegen FA, Schaapveld M, Cutter DJ, et al. Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J Clin Oncol. 2016;34(3):235–243. doi:10.1200/JCO.2015.63.444426573075
   PubMed Web of Science ®Google Scholar
• Peat G, Bergknut C, Frobell R, Joud A, Englund M. Population-wide incidence estimates for soft tissue knee injuries presenting to healthcare in southern Sweden: data from the Skane Healthcare Register. Arthritis Res Ther. 2014;16(4):R162. doi:10.1186/ar467825082600
   PubMed Web of Science ®Google Scholar
• Cancercentrum. Waiting time of lymphoma and chronic lymphoid leukemia according to Swedish standardized care process. Available from: https://www.cancercentrum.se/samverkan/cancerdiagnoser/blod-lymfom-myelom/lymfom-lymfkortelcancer/vardforlopp-lymfom/redovisning-vantetid/. Accessed 930, 2018.
   Google Scholar
• Cancercentrum. Waiting time of myeloma according to Swedish standardized care process. Available from: https://www.cancercentrum.se/samverkan/cancerdiagnoser/blod-lymfommyelom/myelom/vardforlopp-myleom/redovisning-vantetid/. Accessed 930, 2018.
   Google Scholar
• Cancercentrum.Waiting time of acute leukemia according to Swedish standardized care process. Available from: https://www.cancercentrum.se/samverkan/cancerdiagnoser/blod-lymfom-myelom/akut-myeloisk-leukemi-aml-inkl-akut-oklassificerad-leukemi-aul/vardforlopp/redovisning-vantetid/. Accessed 930, 2018.
   Google Scholar
• Cancercentrum. Report of Swedish national quality register for acute myeloid leukemia, 1997–2014. Available from: https://www.cancercentrum.se/globalassets/cancerdiagnoser/blod-lymfom-myelom/aml/aml-arsrapport-2016_20170206.pdf. Accessed 930, 2018.
   Google Scholar
• Cancercentrum. Report of Swedish national quality register for lymphoma, 2000–2017. Available from: https://www.cancercentrum.se/globalassets/cancerdiagnoser/blod-lymfom-myelom/lymfom/rapporter/lymfomarsrapport2000-2017_1.pdf. Accessed 930, 2018.
   Google Scholar
• Cancercentrum. Applicable Care Program of acute myeloid leukemia. Available from: https://www.cancercentrum.se/samverkan/cancerdiagnoser/blod-lymfom-myelom/akut-myeloisk-leukemi-aml-inkl-akut-oklassificerad-leukemi-aul/vardprogram/gallande-vardprogram/. Accessed 1013, 2019.
   Google Scholar
• Cancercentrum. Applicable Care Program of lymphoma. Available from: https://www.cancercentrum.se/samverkan/cancerdiagnoser/blod-lymfom-myelom/lymfom-lymfkortelcancer/vardprogram/. Accessed 1013, 2019.
   Google Scholar
• Castelli R, Ferrari B, Cortelezzi A, Guariglia A. Thromboembolic complications in malignant haematological disorders. Curr Vasc Pharmacol. 2010;8(4):482–494. doi:10.2174/15701611079133079919485900
   PubMed Web of Science ®Google Scholar
• Chen CY, Tai CH, Cheng A, et al. Intracranial hemorrhage in adult patients with hematological malignancies. BMC Med. 2012;10:97. doi:10.1186/1741-7015-10-9722931433
   PubMed Web of Science ®Google Scholar
• Mozos I. Mechanisms linking red blood cell disorders and cardiovascular diseases. Biomed Res Int. 2015;2015:682054. doi:10.1155/2015/68205425710019
   PubMed Web of Science ®Google Scholar
• McCaffery KJ, Irwig L, Turner R, et al. Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial. BMJ. 2010;340:b4491. doi:10.1136/bmj.b449120179125
   PubMed Web of Science ®Google Scholar
• Awsare NS, Green JS, Aldwinckle B, Hanbury DC, Boustead GB, McNicholas TA. The measurement of psychological distress in men being investigated for the presence of prostate cancer. Prostate Cancer Prostatic Dis. 2008;11(4):384–389. doi:10.1038/pcan.2008.2118427569
   PubMed Web of Science ®Google Scholar
• Lu D, Andersson TM, Fall K, et al. Clinical diagnosis of mental disorders immediately before and after cancer diagnosis: a nationwide matched cohort study in Sweden. JAMA Oncol. 2016;2(9):1188–1196. doi:10.1001/jamaoncol.2016.048327124325
   PubMed Web of Science ®Google Scholar
• Baena-Diez JM, Garcia-Gil M, Comas-Cufi M, et al. Association between chronic immune-mediated inflammatory diseases and cardiovascular risk. Heart. 2018;104(2):119–126. doi:10.1136/heartjnl-2017-31127928847852
   PubMed Web of Science ®Google Scholar
• Kim JH, Shah P, Tantry US, Gurbel PA. Coagulation abnormalities in heart failure: pathophysiology and therapeutic implications. Curr Heart Fail Rep. 2016;13(6):319–328. doi:10.1007/s11897-016-0308-627815681
   PubMedGoogle Scholar
• de Lau LM, Leebeek FW, de Maat MP, Koudstaal PJ, Dippel DW. A review of hereditary and acquired coagulation disorders in the aetiology of ischaemic stroke. Int J Stroke. 2010;5(5):385–394. doi:10.1111/j.1747-4949.2010.00468.x20854623
   PubMed Web of Science ®Google Scholar
• Eurich DT, Marrie TJ, Minhas-Sandhu JK, Majumdar SR. Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up. BMJ (Clinical Research ed) 2017;356:j413. doi:10.1136/bmj.j413
   Web of Science ®Google Scholar
• Tseng CH, Huang WS, Muo CH, Chang YJ, Kao CH. Increased depression risk among patients with chronic osteomyelitis. J Psychosom Res. 2014;77(6):535–540. doi:10.1016/j.jpsychores.2014.09.00825258357
   PubMed Web of Science ®Google Scholar
• Siegmann EM, Muller HHO, Luecke C, Philipsen A, Kornhuber J, Gromer TW. Association of depression and anxiety disorders with autoimmune thyroiditis: a systematic review and meta-analysis. JAMA Psychiatry. 2018;75(6):577–584. doi:10.1001/jamapsychiatry.2018.019029800939
   PubMed Web of Science ®Google Scholar
• Vulser H, Wiernik E, Hoertel N, et al. Association between depression and anemia in otherwise healthy adults. Acta Psychiatr Scand. 2016;134(2):150–160. doi:10.1111/acps.2016.134.issue-227238642
   PubMed Web of Science ®Google Scholar
• Sico JJ, Phipps MS, Concato J, et al. Thrombocytopenia and in-hospital mortality risk among ischemic stroke patients. J Stroke Cerebrovasc Dis. 2013;22(7):e99–e102. doi:10.1016/j.jstrokecerebrovasdis.2012.08.00522974703
   PubMed Web of Science ®Google Scholar
• Miller EC, Elkind MS. Infection and stroke: an update on recent progress. Curr Neurol Neurosci Rep. 2016;16(1):2. doi:10.1007/s11910-015-0602-926677196
   PubMed Web of Science ®Google Scholar
• Arkema EV, Svenungsson E, Von Euler M, Sjowall C, Simard JF. Stroke in systemic lupus erythematosus: a Swedish population-based cohort study. Ann Rheum Dis. 2017;76(9):1544–1549. doi:10.1136/annrheumdis-2016-21097328400384
   PubMed Web of Science ®Google Scholar
• Lunning MA, Vose JM. Management of indolent lymphoma: where are we now and where are we going. Blood Rev. 2012;26(6):279–288. doi:10.1016/j.blre.2012.09.00423063143
   PubMed Web of Science ®Google Scholar
• Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol. 1998;9(7):717–720.9739436
   PubMed Web of Science ®Google Scholar
• van der Poel MW, Mulder WJ, Ossenkoppele GJ, et al. Comorbidity and treatment decision-making in elderly non-Hodgkin’s lymphoma patients: a survey among haematologists. Neth J Med. 2014;72(3):165–169.24846934
   PubMed Web of Science ®Google Scholar